Prevention of delayed neuronal cell death by PACAP and its molecular mechanism
Prevention of delayed neuronal cell death by PACAP and its molecular mechanism
批准号:
14380354
负责人:
SHIODA Seiji
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
PACAP可预防海马缺血性延迟性神经元细胞死亡(凋亡)。PACAP抑制MAP激酶家族活性的增加,特别是JNK/SAPK和p38,从而保护凋亡细胞死亡。缺血再灌注后锥体细胞和星形胶质细胞的PACAP受体(PAC1-Rs)表达均增加。锥体细胞变性,反应性星形胶质细胞PAC - 1-R表达增加。PACAP不仅直接抑制凋亡细胞死亡,还通过PAC1-Rs作用于星形胶质细胞。在星形胶质细胞中产生的白细胞介素-6 (IL-6)在预防脑缺血和创伤以及刺激神经元生长方面具有多种作用。注射PACAP后,脑脊液中IL-6分泌受到极大刺激,提示PACAP刺激星形胶质细胞分泌IL-6。我们研究了PACAP对野生型和IL-6小鼠脑缺血后的影响。在野生型动物中,PACAP显著抑制细胞死亡,而在IL-6 KO动物中,PACAP未见细胞保护作用。这些结果表明,PACAP部分通过IL-6抑制凋亡细胞死亡。我们认为,PACAP本身和被PACAP刺激分泌的IL-6协同抑制JNK/SAPK和p38信号通路,从而保护神经元细胞死亡。(1677字)
英文摘要
Ischemic delayed neuronal cell death (apoptotis) in the hippocampus is prevented by PACAP. PACAP inhibits the increasing activity of the MAP kinase family, especially on JNK/SAPK and p38, thereby protecting apoptotic cell death. After the ischemia-reperfusion, both pyramidal cells and astrocytes increased their expression of PACAP receptors (PAC1-Rs). The pyramidal cells degenerated but reactive astrocytes increased their expression of PAC 1-R. PACAP does not only inhibit apoptotic cell death directly, but also affects on astrocytes through PAC1-Rs. Interleukin-6 (IL-6), produced in astrocytes, has several effects on prevention of brain ischemia and trauma and stimulating neuronal growth. IL-6 secretion into the CSF was stimulated extremely after PACAP infusion, suggesting that PACAP stimulates IL-6 secretion from astrocytes. We studied the effects of PACAP on the wild type and IL-6 KO mice after brain ischemia. In wild-type animals, PACAP significantly inhibited cell death but in IL-6 KO animals no cytoprotective effect of PACAP was seen. These results suggest that PACAP inhibits apoptotic cell death partly through IL-6. It is considered that PACAP itself and IL-6, stimulated secretion by PACAP, both synergistically inhibit the JNK/SAPK and p38 signaling pathway, thereby protecting neuronal cell death. (1677 Words)
期刊论文(202)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2004
期刊:
Brain Res. 1016
影响因子:
--
作者:
[Chiyonobu T, Sasaki J, Nagai Y, Takeda S, Funakoshi H, Nakamura T, Sugimoto T, Toda T, Nonaka N.]
通讯作者:
Nonaka N.
Neuronal interactions between galanin-like peptide(GALP)- and orexin- or melanin-concentrating hormone(MCH)-containing neurons in the rat hypothalamus
大鼠下丘脑中甘丙肽样肽(GALP)和含食欲素或黑色素浓缩激素(MCH)神经元之间的神经元相互作用
DOI:
--
发表时间:
2005
期刊:
Regul.Pept. 126
影响因子:
--
作者:
[Masuda, K et al., Takenoya F.]
通讯作者:
Takenoya F.
Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus : immunohistocheinical relationship between PACAP and adenohypophysial hormones.
硬骨鱼脑中的垂体腺苷酸环化酶激活多肽(PACAP)样免疫反应性:PACAP和腺垂体激素之间的免疫组织化学关系。
DOI:
--
发表时间:
2005
期刊:
Regul Pept 126
影响因子:
--
作者:
[Matsuda K, Nagano Y, Uchiyama M, Onoue S, Takahashi A, Kawauchi H, Shioda S]
通讯作者:
Shioda S
Effect of tissue oxygen content by pituitary adenylate cyclase-activating polypeptide(PACAP)-treatment in the central nervous system of mice.
垂体腺苷酸环化酶激活多肽(PACAP)治疗对小鼠中枢神经系统组织氧含量的影响。
DOI:
--
发表时间:
2004
期刊:
Regul.Pept 123
影响因子:
--
作者:
[Ohtaki H]
通讯作者:
Ohtaki H
Ohtaki, H.: "Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice."Acta Neurochir. 86(Suppl). 191-194 (2003)
Ohtaki, H.:“白介素 1 敲除小鼠短暂局灶性缺血后氧化应激的抑制。”Acta Neurochir。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 76 条
A new strategy to conquer obesity by use of a newly discovered neuropeptide GALP
-
批准号:21659059
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.96万
-
财政年份:2009
-
负责人:SHIODA Seiji
-
依托单位:
Demonstration of PACAP on protection of delayed neuronal cell death and its molecular mechanism of neuroregeneration.
-
批准号:20390461
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2008
-
负责人:SHIODA Seiji
-
依托单位:
Functional significance of tumor necrosis factor alpha in inducing retinal ganglion cell death by using gene targeting method
-
批准号:11671758
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:SHIODA Seiji
-
依托单位:
Functional significance of PACAP receptors in regulating secretion and synthesis of vasopressi
-
批准号:10680708
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:SHIODA Seiji
-
依托单位:
Functional significance of PACAP in inhibiting neuronal cell death by using gene targeting method
-
批准号:09558098
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.76万
-
财政年份:1997
-
负责人:SHIODA Seiji
-
依托单位:
PACAP as a neuronal cell death in hibiting function
-
批准号:08458249
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1996
-
负责人:SHIODA Seiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
-
批准号:JCZRLH202601296
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
-
批准号:JCZRLH202600985
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
-
批准号:JCZRLH202601410
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于"热证可灸"理论的中药联合铺棉灸治疗带状疱疹急性期的临床疗效及对血清SP、β-EP、IL-6、IL-10、NSE水平的影响
-
批准号:2026JJ81075
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄迎春
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于IL-6/STAT3通路巨噬细胞极化调控免疫反应在胸膜结核瘤形成中的机制
-
批准号:2026JJ82516
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张锋
-
依托单位:
基于“截断扭转”学说探讨凉膈散通过IL-6/STAT3/RORγt轴调控脓毒症Th17/Treg稳态的机制及临床研究
-
批准号:2026JJ82600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄磊
-
依托单位:
从肝失疏泄探讨肝脏代谢物介导IL-6/STAT3通路调控GABA能系统对睡眠节律影响的机制及逍遥散的干预作用
-
批准号:2026JJ30175
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:滕永杰
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: